EP 2718276 A1 20140416 - HETEROCYCLIC SULFONAMIDE DERIVATIVES
Title (en)
HETEROCYCLIC SULFONAMIDE DERIVATIVES
Title (de)
HETEROCYCLISCHE SULFONAMIDDERIVATE
Title (fr)
DÉRIVÉS DE SULFONAMIDE HÉTÉROCYCLIQUE
Publication
Application
Priority
- IN 1634DE2011 A 20110609
- CN 201210175145 A 20120531
- IB 2012052860 W 20120606
Abstract (en)
[origin: WO2012168884A1] The present invention relates to compounds (I) and pharmaceutically acceptable salts thereof. The compounds have been demonstrated as inhibitors of MEK and therefore may be useful in the treatment of hyperproliferative diseases like cancer and inflammation.
IPC 8 full level
C07D 307/79 (2006.01); A61K 31/343 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP)
A61P 1/08 (2017.12); A61P 25/24 (2017.12); A61P 29/00 (2017.12); A61P 35/00 (2017.12); A61P 43/00 (2017.12); C07D 307/79 (2013.01)
Citation (search report)
See references of WO 2012168884A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
WO 2012168884 A1 20121213; AU 2012265844 A1 20130502; BR 112013031201 A2 20170131; CA 2838029 A1 20121213; EA 201391820 A1 20141230; EP 2718276 A1 20140416; IN 123DEN2014 A 20150522; JP 2014517004 A 20140717; KR 20140034898 A 20140320; MX 2013014398 A 20140321
DOCDB simple family (application)
IB 2012052860 W 20120606; AU 2012265844 A 20120606; BR 112013031201 A 20120606; CA 2838029 A 20120606; EA 201391820 A 20120606; EP 12730043 A 20120606; IN 123DEN2014 A 20140107; JP 2014514204 A 20120606; KR 20147000283 A 20120606; MX 2013014398 A 20120606